In NYU Langone’s Division of Neurocritical Care, our research faculty are engaged in investigator-initiated research on quality improvement in neurocritical care; intracerebral hemorrhage, subarachnoid hemorrhage, and ischemic stroke; status epilepticus; COVID-19; education; social determinants of health; and end-of-life ethical, social, medical, and legal controversies.

We have maintained a prospective database of patients with intracerebral hemorrhage and subarachnoid hemorrhage called Neurological Emergencies Outcomes at NYU (NEON) since 2014, which includes medical and social history, data on the clinical examination on admission and discharge, radiology results, medications, vitals, laboratory findings, and outcome data from 3 months and 12 months after stroke.

Neurologic injury is sometimes associated with permanent physical, intellectual, and emotional problems that affect basic activities of daily living and long-term quality of life. Through NEON, we can identify specific findings during hospitalization and before injury that may be linked to outcomes. This information may lead to the development of improved treatments and rehabilitation interventions that specifically address the needs of patients with neurologic injury.

NYU Langone is also a member of the National Institute of Health’s StrokeNet, a network of more than 200 hospitals across the United States that serves as the infrastructure and pipeline for potential new treatments for people who have had a stroke and those at risk for stroke. Through StrokeNet, we conduct research studies and clinical trials at NYU Langone to provide better outcomes for people with neurocritical illnesses.

We are committed to identifying the best practices for care of patients in the neurocritical care unit and their loved ones.